From the Guidelines
Treatment with levothyroxine for slightly elevated TSH with normal T4 (subclinical hypothyroidism) is not automatically recommended for everyone, and the decision should be individualized based on several factors, including symptoms, TSH levels, and risk factors, as suggested by the most recent guideline update 1. When considering treatment, the following factors should be taken into account:
- Symptoms of hypothyroidism, such as fatigue, cold intolerance, and weight gain
- TSH levels, with treatment considered for levels persistently or significantly elevated
- Presence of positive thyroid antibodies
- Pregnancy or plans to conceive
- Certain risk factors, such as cardiovascular disease The typical starting dose of levothyroxine is 25-50 mcg daily, taken in the morning on an empty stomach, at least 30-60 minutes before food, with regular monitoring of blood tests every 6-8 weeks initially to adjust the dose, aiming for a TSH within the normal range, as recommended by the guideline update 1. It's essential to balance the potential benefits of treating subclinical hypothyroidism against the risks of overtreatment, which can lead to symptoms of hyperthyroidism or long-term issues like osteoporosis, and to consider the latest evidence and guidelines when making treatment decisions, such as those provided by the American Society of Clinical Oncology (ASCO) guideline update 1.